Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Zymergen
Biotech
7 months after biotech pivot, Zymergen is acquired by Ginkgo
Ginkgo will look for “strategic alternatives” for Zymergen’s drug discovery business once the $300 million sale is complete.
James Waldron
Jul 25, 2022 9:00am
Zymergen’s fledgling stock tumbles amid CEO exit, product delays
Aug 4, 2021 10:45am
Innovation Endeavors launches Deep Life startup ecosystem
Apr 10, 2019 8:00am
Synthetic biology manufacturer Zymergen raises another $400M
Dec 14, 2018 4:29pm
SoftBank, Saudi Arabia team up to create $100B tech fund
Oct 14, 2016 3:38am
Zymergen continues SynBio fundraising frenzy
Oct 11, 2016 10:38am
